Biopharmaceutical company eFFECTOR Therapeutics has completed a $45 million Series A financing. Investors include U.S. Venture Partners, Abingworth, Novartis Venture Funds, SR One, Astellas Venture Management, Osage University Partners and Mission Bay Capital.
You are browsing the archive for U. S. Venture Partners - peHUB.
San Francisco-based startup Chute announced Tuesday it raised $7 million Series A round of funding led by Foundry Group, with existing investors Freestyle Capital and U.S. Venture Partners also participating. The company, which came out out of Y Combinator, previously raised about $3 million in funding from institutional ind individual investors, including Klout co-founder and CEO Joe Fernandez.
Clustrix, a San Francisco-based developer of clustered databases to help make them manageable and searchable, has raised a $16.5 million Series C round of funding from current investors Sequoia Capital, U.S. Venture Partners, ATA Ventures and individual investor Don Listwin, a former executive of Cisco. The company, which was founded in late 2005 and came out of Y Combinator, has raised now raised $46.5 million to date.
Diablo Technologies Inc., an Ottawa, Ontario-based maker of memory system interface products, has raised C$7.5 million in additional financing, expanding its latest venture capital round to C$36 million. The new funds include a first-time investment from U.S. Venture Partners (USVP), with USVP partner Chris Rust joining Diablo’s board of directors. Additional funds came from the company’s existing investors, which include Battery Ventures, BDC Venture Capital, Celtic House Venture Partners and Hasso Plattner Ventures.
CardioKinetix, a Menlo Park, Calif.-based medical device company, has completed the $23 million second-tranche of its Series E financing, bringing the total round to $48 million. Panorama Capital is the company’s newest investor. It joins previous investors U.S. Venture Partners, JPMorgan Partners, New Leaf Venture Partners, SV Life Sciences, H&Q Healthcare Investors, and H&Q Life Sciences Investors.
Medical device company Intersect ENT has raised a $30 million Series D round of funding that was led by new investor Norwest Venture Partners. Also participating in the round were existing investors Kleiner Perkins Caufield & Byers, U.S. Venture Partners, PTV Sciences and Medtronic. The company, which develops therapies for ear, nose and throat surgeons, previously raised $30 million in known funding.
Livefyre said it raised a $15M Series C investment in a deal led by U.S. Venture Partners and joined by existing investors Greycroft Partners, Cue Ball, HillsVen Group, and ff Venture Capital. The money will support new growth and expansion into new markets.
U.S. Venture Partners has appointed Emily Melton as venture partner. Melton previously was a partner at DFJ, where she was actively involved in a number of companies in the firm`s consumer and enterprise portfolio. After DFJ, Emily was with Mayfield Fund, where she was involved in formulating the firm`s mobile and consumer investment strategy.
U.S. Venture Partners, Mayfield Fund and undisclosed individual investors have put $4.3 million into Easilydo, which launches today. San Francisco-based Easilydo provides a personal productivity app for the iOS.